Work

EV-202: A phase II study of enfortumab vedotin in patients with select previously treated locally advanced or metastatic solid tumors.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.tps3647

Authors: Justine Yang Bruce, Lajos Pusztai, Fadi S. Braiteh, Seema Rao Gorla, Chunzhang Wu, Joaquina Baranda

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Yale University, Comprehensive Cancer Centers of Nevada, Astellas Pharma (United States), University of Kansas, The University of Kansas Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3031345044

Cites:

Cited by: 13

Related to: 10